Tessellis S.p.A. (TSL.MI)
EUR 0.15
(1.73%)
EUR 0.15
(1.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 42.25 Million | 4.41 Million | 34.86 Million | 12.7 Million | 46.12 Million | -721 Thousand |
| Net Income | -62.2 Million | -34.73 Million | -20.61 Million | -22.2 Million | -16.46 Million | -45.28 Million |
| Depreciation & Amortization | 81.56 Million | 41.09 Million | 43.04 Million | 41.32 Million | 42.17 Million | 47.95 Million |
| Deferred income taxes | - | - | - | 13.24 Million | -10.64 Million | 8.46 Million |
| Stock-based compensation | - | - | - | 11 Thousand | 5000.00 | -13 Thousand |
| Change in working capital | 2.93 Million | -10.19 Million | 7.63 Million | -27.62 Million | 19.2 Million | -25.32 Million |
| Other non-cash items | 7.33 Million | 8.24 Million | 4.8 Million | 7.94 Million | 11.85 Million | 13.48 Million |
| Investing Cash Flow | -33.69 Million | 7.1 Million | -39.25 Million | -13.59 Million | -16.86 Million | -9.41 Million |
| Investments in PPE | -50.69 Million | -23.23 Million | -39.42 Million | -32.81 Million | -43.39 Million | -18.16 Million |
| Acquisitions | - | - | - | - | 16.08 Million | 8.53 Million |
| Investment purchases | -39 Thousand | -6000.00 | - | - | -374 Thousand | -280 Thousand |
| Sales/Maturities of investments | - | - | 41 Thousand | 101 Thousand | - | - |
| Other Investing Activities | -1.7 Million | 30.34 Million | 128 Thousand | 19.11 Million | 26.52 Million | 9.02 Million |
| Financing Cash Flow | -9.18 Million | -7.54 Million | 11.57 Million | -6.32 Million | -36.57 Million | -16.57 Million |
| Debt repayment | -13.01 Million | -3.43 Million | -899 Thousand | -901 Thousand | -10.41 Million | -10.91 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.82 Million | - | 11.46 Million | - | - | - |
| Other Financing Activities | -14 Thousand | -4.1 Million | 1.01 Million | -5.42 Million | -26.16 Million | -5.65 Million |
| Accounts receivables | -5.97 Million | -5 Million | -2.16 Million | -520 Thousand | 9.29 Million | 1.93 Million |
| Accounts payables | 19.27 Million | 4.51 Million | 17.75 Million | -9.39 Million | -76.78 Million | -19.31 Million |
| Inventory | 18.26 Million | -1000.00 | -197 Thousand | - | - | - |
| Other working capital | -28.63 Million | -10.19 Million | -7.75 Million | -17.71 Million | 86.69 Million | -7.93 Million |
| Cash at beginning of period | 8.26 Million | 3.93 Million | 4.43 Million | 11.65 Million | 18.97 Million | 1.46 Million |
| Cash at end of period | 7.71 Million | 8.26 Million | 11.61 Million | 4.43 Million | 11.65 Million | 18.97 Million |
| Capital Expenditure | -50.69 Million | -23.23 Million | -39.42 Million | -32.81 Million | -43.39 Million | -18.16 Million |
| Effect of forex changes on cash | - | 354 Thousand | - | - | - | 44.21 Million |
| Net cash flow / Change in cash | -554 Thousand | 4.33 Million | 7.18 Million | -7.21 Million | -7.32 Million | 17.51 Million |
| Free Cash Flow | -8.43 Million | -18.82 Million | -4.56 Million | -20.11 Million | 2.72 Million | -18.88 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13 Million | -13 Million | -62.2 Million | -17.78 Million | -17.78 Million | -26.81 Million |
| Depreciation & Amortization | 35.49 Million | - | 81.56 Million | 19.83 Million | 19.83 Million | 41.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 27.71 Million | - | 2.93 Million | 298 Thousand | 298 Thousand | 1.83 Million |
| Other non-cash items | 13 Million | 13 Million | 7.33 Million | 4.56 Million | 4.56 Million | 83.99 Million |
| Investing Cash Flow | -34.63 Million | - | -33.69 Million | -6.62 Million | -6.62 Million | -20.44 Million |
| Investments in PPE | -2.77 Million | - | -50.69 Million | -4.49 Million | -4.49 Million | -24.37 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -3.48 Million | - | -39 Thousand | 91 Thousand | - | -130 Thousand |
| Sales/Maturities of investments | 12 Thousand | - | - | - | - | - |
| Other Investing Activities | -13.67 Million | - | -1.7 Million | -2.13 Million | -2.13 Million | 4.06 Million |
| Financing Cash Flow | -8.7 Million | - | -9.18 Million | -244.5 Thousand | -244.5 Thousand | -8.69 Million |
| Debt repayment | -6.47 Million | - | -13.01 Million | -3.16 Million | - | -9.84 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 23 Thousand | - | 7.82 Million | 4 Million | - | 3.82 Million |
| Other Financing Activities | -2.25 Million | - | -14 Thousand | -244.5 Thousand | -244.5 Thousand | -12 Thousand |
| Accounts receivables | -4.05 Million | - | -5.97 Million | 797 Thousand | 797 Thousand | -7.57 Million |
| Accounts payables | 28.58 Million | - | 19.27 Million | 10.31 Million | - | 8.96 Million |
| Inventory | -79 Thousand | - | 18.26 Million | 4.17 Million | 4.17 Million | 9.92 Million |
| Other working capital | 3.26 Million | - | -28.63 Million | -4.67 Million | -4.67 Million | -9.48 Million |
| Cash at beginning of period | 7.71 Million | - | 8.26 Million | 7.56 Million | - | 8.26 Million |
| Cash at end of period | 9.67 Million | - | 7.71 Million | 7.71 Million | 36 Thousand | 7.56 Million |
| Capital Expenditure | -2.77 Million | - | -50.69 Million | -4.49 Million | -4.49 Million | -24.37 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.96 Million | - | -554 Thousand | 146 Thousand | 36 Thousand | -700 Thousand |
| Free Cash Flow | 42.03 Million | - | -8.43 Million | 2.41 Million | 2.41 Million | 4.05 Million |
VALIANTLAB
FENC
CCNTF
176A
IVX
BRY